See today's BioWorld MedTech
To read the full story, subscribe or sign in.

Two more studies for Lunit Insight MMG in breast cancer screening

Oct. 24, 2024
By Marian (YoonJee) Chu
A recent retrospective cohort study of Insight MMG highlighted potential of Lunit Inc.’s artificial intelligence-powered breast cancer screening tool in detecting “subtle signs of cancer” earlier for women.
BioWorld MedTech Artificial intelligence Cancer Oncology Women's health Diagnostics Digital health Europe